Does PEMBROLIZUMAB Cause Cholangitis? 357 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 357 reports of Cholangitis have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.4% of all adverse event reports for PEMBROLIZUMAB.
357
Reports of Cholangitis with PEMBROLIZUMAB
0.4%
of all PEMBROLIZUMAB reports
38
Deaths
212
Hospitalizations
How Dangerous Is Cholangitis From PEMBROLIZUMAB?
Of the 357 reports, 38 (10.6%) resulted in death, 212 (59.4%) required hospitalization, and 14 (3.9%) were considered life-threatening.
Is Cholangitis Listed in the Official Label?
Yes, Cholangitis is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Cholangitis?
NIVOLUMAB (389)
PACLITAXEL (289)
GEMCITABINE (225)
TACROLIMUS (213)
BEVACIZUMAB (176)
FLUOROURACIL (175)
DURVALUMAB (157)
OXALIPLATIN (147)
IRINOTECAN (146)
ATEZOLIZUMAB (145)
Which PEMBROLIZUMAB Alternatives Have Lower Cholangitis Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G